Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases (2019)
- Authors:
- USP affiliated authors: ULRICH, ALEXANDER HENNING - IQ ; GLASER, TALITA - IQ ; GIACOMELLI, ÁGATHA OLIVEIRA - IQ ; RIBEIRO, DEIDIANE ELISA - IQ ; GRANATO, ALESSANDRO EUSTAQUIO CAMPOS - IQ
- Unidade: IQ
- DOI: 10.1007/978-3-030-31206-0_14
- Subjects: DOENÇAS NEURODEGENERATIVAS; DOENÇAS CARDIOVASCULARES; NEUROGENÉTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: Springer Nature
- Publisher place: Cham
- Date published: 2019
- Source:
- Título: Stem Cells: Therapeutic Applications
- Volume/Número/Paginação/Ano: 406 p
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ANDREJEW, Roberta et al. Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases. Stem Cells: Therapeutic Applications. Tradução . Cham: Springer Nature, 2019. . Disponível em: https://doi.org/10.1007/978-3-030-31206-0_14. Acesso em: 26 jan. 2026. -
APA
Andrejew, R., Glaser, T., Giacomelli, Á. O., Ribeiro, D. E., Godoy, M. A. de, Granato, A. E. C., & Ulrich, H. (2019). Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases. In Stem Cells: Therapeutic Applications. Cham: Springer Nature. doi:10.1007/978-3-030-31206-0_14 -
NLM
Andrejew R, Glaser T, Giacomelli ÁO, Ribeiro DE, Godoy MA de, Granato AEC, Ulrich H. Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases [Internet]. In: Stem Cells: Therapeutic Applications. Cham: Springer Nature; 2019. [citado 2026 jan. 26 ] Available from: https://doi.org/10.1007/978-3-030-31206-0_14 -
Vancouver
Andrejew R, Glaser T, Giacomelli ÁO, Ribeiro DE, Godoy MA de, Granato AEC, Ulrich H. Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases [Internet]. In: Stem Cells: Therapeutic Applications. Cham: Springer Nature; 2019. [citado 2026 jan. 26 ] Available from: https://doi.org/10.1007/978-3-030-31206-0_14 - Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease
- The P2X7 receptor: central hub of brain diseases
- Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires]
- Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases
- ATP and spontaneous calcium oscillations control neural stem cell fate determination in Huntington’s disease: a novel approach for cell clock research
- Stem cells: principles and applications
- A novel decellularization method to produce brain scaffolds
- Curcuminoid-tailored interfacial free energy of hydrophobic fibers for enhanced biological properties
- P2X7 receptor signaling in stress and depression
- Effect of treatment with the antioxidant N-acetyl-l-cysteine or the purinergic antagonist (BBG) in the mam model of schizophrenia
Informações sobre o DOI: 10.1007/978-3-030-31206-0_14 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
